Skip to main content
. 2020 Sep 24;12(10):2917. doi: 10.3390/nu12102917

Table 2.

Changes in dietary intake, anthropo-metabolic outcomes, and gut microbiome during the study.

Control Group Vegan Group Treatment Effect p Value a p Value b
Baseline Week 16 Baseline Week 16
Total Physical activity (metabolic equivalents) 2840 (2064–3616) 2107 (1555–2658) * 2982 (1696–4267) 2000 (1394–2606) −248 (−1549 to +1053) 0.71 0.87
Dietary Intake
Caloric Intake (kcal/day) 1726 (1606–1847) 1692 (1562–1821) 1827 (1689–1965) 1294 (1212–1376) *** −498 (−696 to −300) <0.001 <0.001
Total Fat (g/day) 72.2 (66.1–78.3) 71.5 (63.9–79.0) 74.1 (67.9–80.4) 24.3 (21.7–26.9) *** −49.1 (−58.5 to −39.8) <0.001 <0.001
Total Carbohydrate (g/day) 204 (187–221) 196 (178–214) 222 (202–241) 236 (219–254) +22.6 (−6.5 to +51.7) 0.13 0.17
Total Protein (g/day) 67.2 (62.2–72.1) 68.9 (63.1–74.6) 69.0 (63.9–74.1) 42.9 (40.0–45.7) *** −27.9 (−36.0 to −19.7) <0.001 <0.001
Animal Protein (g/day) 37.5 (32.5–42.4) 39.3 (33.4–45.3) 38.5 (33.7–43.2) 1.2 (0.5–1.9) *** −39.1 (−46.4 to −31.9) <0.001 <0.001
Veg Protein (g/day) 29.7 (26.8–32.6) 29.5 (26.0–33.0) 30.6 (27.5–33.7) 41.7 (39.0–44.3) *** +11.3 (+6.6 to +16.0) <0.001 <0.001
Cholesterol (mg/day) 227 (190–263) 243 (201–285) 227 (196–258) 5.1 (3.3–6.9) *** −238 (−285 to −191) <0.001 <0.001
Total SFA (g/day) 21.7 (19.3–24.0) 21.9 (18.9–24.9) 23.3 (20.4–26.1) 4.8 (4.2–5.4) *** −18.7 (−22.7 to −14.8) <0.001 <0.001
Total MUFA (g/day) 26.7 (24.1–29.3) 25.8 (23.0–28.5) 26.4 (24.2–28.6) 7.9 (7.0–8.7) *** −17.6 (−21.2 to −14.0) <0.001 <0.001
Total PUFA (g/day) 17.9 (16.4–19.5) 17.8 (15.8–19.9) 18.4 (16.7–20.2) 9.0 (7.9–10.2) *** −9.3 (−12.1 to −6.6) <0.001 <0.001
Total Dietary Fiber (g/day) 23.1 (21.0–25.2) 23.1 (20.7–25.4) 24.0 (21.6–26.5) 33.2 (30.8–35.6) *** +9.2 (+5.6 to +12.8) <0.001 <0.001
Soluble Fiber (g/day) 6.0 (5.5–6.5) 6.6 (6.0–7.2) * 6.9 (6.2–7.5) 8.5 (7.8–9.2) *** +1.0 (+0.1 to +2.0) 0.03 0.01
Insoluble Fiber (g/day) 17.0 (15.3–18.8) 16.4 (14.5–18.2) 17.1 (15.1–19.0) 24.6 (22.7–26.4) *** +8.2 (+5.2 to +11.1) <0.001 <0.001
Anthropo-Metabolic Outcomes
Weight (kg) 93.4 (90.1–96.7) 92.9 (89.6–96.3) 92.9 (89.7–96.1) 86.5 (83.5–89.5) *** −5.9 (−7.0 to −4.9) <0.001 <0.001
BMI (kg/m2) 33.6 (32.6–34.5) 33.4 (32.4–34.4) 32.6 (31.8–33.5) 30.5 (29.6–31.3) *** −2.0 (−2.4 to −1.6) <0.001 <0.001
Fat Mass (kg) 42.0 (39.7–44.2) 41.7 (39.4–44.1) 39.8 (37.7–42.0) 35.7 (33.6–37.9) *** −3.9 (−4.6 to −3.1) <0.001 <0.001
VAT Volume (cm3) 1590 (1365–1814) 1589 (1360–1818) 1511 (1291–1732) 1271 (1084–1457) *** −240 (−345 to −135) <0.001 <0.001
PREDIM (mg/min/kg) 4.4 (4.0–4.8) 4.2 (3.8–4.6) 4.0 (3.7–4.3) 4.8 (4.4–5.1) *** +0.83 (+0.48 to +1.2) <0.001 <0.001
Gut Microbiota Composition
Diversity 1.6 (1.5–1.7) 1.8 (1.7–1.9) *** 1.7 (1.6–1.8) 1.7 (1.6–1.8) −0.20 (−0.34 to −0.06) 0.0043 0.003
Firmicutes 60,997 (41,121–80,874) 60,599 (51,612–69,586) 52,038 (41,221–62,856) 64,734 (53,368–76,100) +13,094 (−11,808 to +37,996) 0.30 0.42
Firmicutes % 52.2 (48.7–55.7) 49.8 (46.6–52.9) 55.4 (51.7–59.1) 54.6 (51.4–57.9) +1.7 (−2.7 to +6.1) 0.45 0.72
Bacteroidetes 41,690 (33,401–49,980) 53,871 (41,691–66,051) 31,944 (24,747–39,141) 42,855 (34,088–51,622) * −1270 (−17,950 to +15,409) 0.88 1.00
Bacteroidetes % 37.6 (34.1–41.1) 38.3 (34.9–41.7) 31.6 (28.4–34.8) 35.1 (31.4–38.8) +2.8 (−2.0 to +7.5) 0.25 0.06
Enterobacteriaceae 600 (−109–1308) 709 (−153–1570) 293 (135–451) 683 (−79.0–1444) +280.6 (−545 to +1106) 0.50 0.44
Enterobacteriaceae % 0.47 (0.02–0.93) 0.66 (0.02–1.3) 0.73 (0.03–1.4) 0.47 (0.02–0.92) −0.44 (−1.3 to +0.45) 0.33 0.25
Firmicutes:Bacteroidetes ratio 3.0 (0.38–5.6) 2.0 (0.92–3.1) 2.4 (1.6–3.1) 2.3 (1.7–2.9) +0.90 (−0.76 to +2.6) 0.28 0.26
Butyrate producing bacteria 41,781 (34,410–49,152) 34358 (27,310–41,407) * 37,169 (29,540–44,799) 38,143 (30,371–45,915) +8396 (−4458 to +21249) 0.20 0.32
Butyrate producing bacteria % 22.0 (19.5–24.5) 19.4 (16.8–21.9) 23.4 (21.5–25.2) 21.2 (19.2–23.2) +0.48 (−4.0 to +5.0) 0.83 0.74
Prevotella 240 (104–376) 554 (49.4–1059) 224 (111–336) 402 (169–636) −135 (−711 to +439) 0.64 0.61
Prevotella % 0.35 (0.09–0.60) 1.15 (0.08–2.2) 0.69 (0.01–1.4) 0.84 (0.02–1.7) −0.65 (−2.1 to +0.8) 0.39 0.56
Akkermansia 1089 (495–1684) 5073 (66.0–10080) 2256 (640–3871) 3215 (1873–4557) −3024 (−8211 to +2163) 0.25 0.26
Akkermansia % 1.4 (0.74–2.1) 2.4 (0.85–4.0) 2.1 (1.0–3.1) 2.3 (1.5–3.2) −0.74 (−2.6 to +1.1) 0.43 0.40
Faecalibacterium prausnitzii 6935 (4905–8966) 7142 (4502–9783) 6304 (4127–8481) 12405 (8417–16394) * +5895 (+506 to +11283) 0.03 0.17
Faecalibacterium prausnitzii % 7.2 (5.2–9.2) 5.3 (3.8–6.9) 5.5 (4.3–6.8) 8.8 (7.0–10.6) *** +5.1 (+2.4 to +7.9) 0.0003 0.002
Bacteroides fragilis 31212 (23918–38505) 602 (−275–1478) *** 10641 (5513–15769) 524 (−19.0–1067) *** +20493 (+11790 to +29195) <.001 <.001
Bacteroides fragilis % 27.1 (23.6–30.6) 0.3 (0.0–0.60) *** 8.3 (5.1–11.5) 0.40 (0.10–0.70) *** +18.9 (+14.2 to +23.7) <.001 <.001
Clostridium 844 (529–1160) 956 (705–1206) 631 (432–829) 880 (694–1066) +138 (−245 to +521) 0.48 0.62
Clostridium % 0.72 (0.54–0.90) 0.74 (0.58–0.90) 0.68 (0.55–0.81) 0.76 (0.63–0.88) +0.05 (−0.17 to +0.27) 0.63 0.71
Methanobrevibacter 71.4 (22.9–120) 506 (156–856) * 299 (37.1–560) 826 (−2.8–1655) +93.1 (−817 to +1003) 0.84 0.51
Methanobrevibacter % 0.09 (0.03–0.14) 0.35 (0.14–0.57) ** 0.23 (0.07–0.39) 0.57 (0.18–0.96) +0.07 (−0.35 to +0.49) 0.74 0.25
Eubacterium 0.42 (0.05–0.79) 2.0 (0.37–3.7) * 1.0 (0.08–2.0) 0.9 (0.03–1.8) −1.7 (−3.5 to +0.09) 0.06 0.05
Eubacterium % 0.001 (0.00002–0.001) 0.002 (0.0002–0.003) 0.0009 (0.0001–0.002) 0.002 (−0.0005–0.004) −0.0003 (−0.002 to +0.002) 0.77 0.88
Bifidobacterium 1254 (412–2096) 1712 (764–2659) 1278 (738–1818) 2313 (1286–3339) * +577 (−700 to +1854) 0.37 0.89
Bifidobacterium % 1.4 (0.48–2.3) 1.8 (0.35–3.3) 1.3 (0.79–1.8) 1.7 (1.1–2.3) −0.05 (−0.91 to +0.81) 0.91 0.64
Proteobacteria 5278 (3672–6883) 5195 (3305–7086) 3561 (2503–4619) 4165 (2798–5533) +686 (−1622 to +2994) 0.56 0.78
Proteobacteria % 4.9 (3.7–6.0) 4.0 (3.0–5.1) 4.4 (3.2–5.5) 3.1 (2.4–3.9) * −0.40 (−2.0 to +1.2) 0.61 0.58
Actinobacteria 2736 (1395–4077) 2247 (1261–3233) 2459 (1716–3203) 2729 (1658–3800) +758 (−1071 to +2588) 0.41 0.85
Actinobacteria % 3.1 (1.9–4.4) 2.9 (1.2–4.7) 2.6 (2.0–3.1) 2.4 (1.6–3.2) +0.05 (−1.4 to +1.5) 0.94 0.91
Ruminococcaceae 15,842 (11,727–19,956) 15775 (12,261–19,289) 18,807 (14,337–23,277) 22,265 (17,204–27,326) +3525 (−4962 to +12011) 0.41 0.96
Ruminococcaceae % 15.4 (13.0–17.8) 12.9 (10.5–15.2) 19.0 (16.7–21.3) 18.5 (16.2–20.8) +2.1 (−1.4 to +5.5) 0.24 0.66
Lachnospiraceae 26,182 (20,879–31,485) 18,224 (12,241–24,207) ** 22,871 (18,631–27,111) 15,881 (11,212–20,550) * +968 (−7106 to +9042) 0.81 0.79
Lachnospiraceae % 24.4 (22.1–26.7) 15.4 (11.3–19.4) *** 24.8 (22.5–27.1) 16.9 (13.6–20.2) *** +1.2 (−4.6 to +7.0) 0.69 0.91
Roseburia 5993 (4634–7351) 5639 (4367–6912) 5821 (4255–7387) 6649 (4953–8345) +1181 (−1469 to +3831) 0.38 0.34
Roseburia % 5.8 (4.7–6.9) 5.1 (4.1–6.1) 6.4 (5.3–7.5) 6.0 (4.8–7.2) +0.28 (−1.6 to +2.2) 0.77 0.90
Anaerostipes 1502 (1020–1985) 2061 (1496–2625) 1481 (1103–1858) 2203 (1614–2792) * +164 (−772 to +1100) 0.73 0.45
Anaerostipes % 1.4 (1.1–1.8) 1.5 (1.2–1.8) 1.6 (1.2–1.9) 1.8 (1.4–2.1) +0.10 (−0.48 to +0.69) 0.72 0.33
Megasphaera 324 (−264–912) 334 (−270–938) 60.7 (19.5–102) 123 (−9.2–255) +51.8 (−58.0 to +162) 0.35 0.80
Megasphaera % 0.72 (−0.67–2.1) 0.62 (−0.42–1.7) 0.12 (0.00–0.25) 0.19 (−0.05–0.42) +0.16 (−0.24 to +0.56) 0.42 0.67

Data are means with 95% confidence interval (CI) mean. The treatment effect, which is tested by the group-by-time interaction in a repeated measures ANOVA model, does effectively compare the differences in outcomes from baseline to week 16 between the two study arms. Bonferroni correction for multiple comparisons was used for four hypotheses at p = 0.0125 (0.05/4). The rest of the outcomes, performed in an exploratory manner, are presented for complete overview. The treatment effect is the difference in outcomes, from baseline to week 16, between the vegan and control group. Diversity is defined as alpha diversity, which was calculated using an abundance-weighted phylogenetic diversity measure. Values listed under gut microbiota composition values are read counts and relative abundances (%). Relative abundance was calculated by dividing the number of reads assigned to each taxon by the total number of filtered reads. Listed p values are for interactions assessed by repeated measures ANOVA, first unadjusted (p-value a: unadjusted, group x time) and then adjusted for age and gender (p-value b, including all study participants). * p < 0.05, ** p < 0.01, and *** p < 0.001 for within-group changes from baseline assessed by paired comparison t tests. Abbreviations: SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; BMI, body mass index; VAT, visceral adipose tissue; PREDIM (PREDIcted M, insulin sensitivity index).